Search results
Bristol-Myers stock falls despite Q1 beat (NYSE:BMY)
Seeking Alpha· 3 days agoBristol-Myers Squibb (BMY) stock dips even as the company topped consensus with Q1 2024 results, despite headwinds in its growth portfolio. Read more...
Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts
InvestorPlace· 3 days agoBristol-Myers Squibb (NYSE:BMY) layoffs are a hot topic on Thursday after the biopharmaceutical...
Why Bristol Myers Squibb Stock Is Sinking Today
Motley Fool via Yahoo Finance· 3 days agoShares of Bristol Myers Squibb (NYSE: BMY) were down 8.3% as of 11:19 a.m. ET on Thursday. The sell-off came after the big drugmaker announced its...
Bristol Myers Squibb closes immuno-oncology, cell therapy-focused Redwood City site
FierceBiotech· 2 days agoOne of Chris Boerner’s first tours as the new CEO of Bristol Myers Squibb was of a 256,000...
Bristol Myers Squibb to Shut 256K sf Campus in Redwood City
The Real Deal· 2 days agoBristol Myers Squibb will close a 256,000-square-foot campus in Redwood City and squish operations...
Bristol-Myers Squibb First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. via Yahoo Finance· 1 day agoBristol-Myers Squibb (NYSE:BMY) First Quarter 2024 Results Key Financial Results Revenue: US$11.9b...
Reviva Pharmaceuticals (NASDAQ:RVPH) vs. Bristol-Myers Squibb (NYSE:BMY) Head to Head Survey
ETF DAILY NEWS· 4 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) and Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) are both medical companies, but which is the better investment? We will compare the ...
Is Bristol Myers Squibb Stock a Millionaire Maker?
Motley Fool via Yahoo Finance· 3 days agoMany top healthcare stocks provide investors with long-term stability, promising growth prospects, and in some cases even a dividend. Yet, investors...
Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions
Benzinga via Yahoo Finance· 3 days agoThursday, Bristol Myers Squibb & Co (NYSE:BMY) posted first-quarter revenues of $11.9 billion,...
Bristol-Myers Squibb (NYSE:BMY) Forecasted to Post Q3 2024 Earnings of $1.67 Per Share
ETF DAILY NEWS· 3 days agoBristol-Myers Squibb (NYSE:BMY – Free Report) – Analysts at Zacks Research cut their Q3 2024 earnings per share (EPS) estimates for Bristol-Myers Squibb in a note issued to investors on Tuesday ...